SILVERMAN LOU 4

What Happened
Lou Silverman, a director of Insight Molecular Diagnostics, received a grant of 26,943 restricted stock units (RSUs) on June 11, 2026. The grant is reported as an award/acquisition (code A) at $0.00 per share in the Form 4 filed on June 15, 2026 (period of report 6/11/2026). The filing lists the acquisition amount as $0 because this is a compensation award rather than a market purchase.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (timely filing).
• Transaction type/code: Award/Grant (A) — 26,943 RSUs granted at $0.00.
• Total reported acquisition value on the Form 4: $0 (award/grant).
• Shares owned after transaction: Not specified in the filing.
• Footnote: RSUs vest on the date of the next annual shareholders’ meeting, subject to Silverman’s continued service from grant date until vesting (per footnote F1).
• No indication of a 10b5-1 plan, tax-withholding sale, or immediate sale of shares.

Context
RSUs are compensation awards that convert to actual shares only upon vesting; they do not represent immediate market purchases and typically cannot be sold until they vest. Such grants are common for directors and employees and are informational rather than a direct buy/sell signal. Because the award vests in the future and depends on continued service, it does not reflect immediate insider buying or selling.